Profiel
Mr. Tom Burnett is Director & President-Medical Isotopes at Nordion (Canada), Inc. and President & Director at LPBP, Inc. He is on the Board of Directors at Nordion (Canada), Inc. and LPBP, Inc. He received his undergraduate degree from the University of Western Ontario, a graduate degree from Queen's University and an MBA from Richard Ivey School of Business.
Actieve functies van Tom Burnett
| Bedrijven | Functie | Begin |
|---|---|---|
| NORDION INC | Director/Board Member | 01-01-2006 |
| LPBP INC | Chairman | - |
Opleiding van Tom Burnett
| Queen's University | Graduate Degree |
| University of Western Ontario | Undergraduate Degree |
| Richard Ivey School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Nordion (Canada), Inc.
 Nordion (Canada), Inc. Pharmaceuticals: MajorHealth Technology Nordion (Canada), Inc. provides drug discovery and development research services. It specializes in health science, gamma irradiation, radiopharmaceutical, gamma sterilization, medical isotopes, and production irradiators. The company was founded in 1946 and is headquartered in Ottawa, Canada. | Health Technology |
LPBP, Inc.
 LPBP, Inc. Financial ConglomeratesFinance LPBP, Inc. is a development stage company. It was previously engaged in blood products business and clinical laboratories services. The company was founded on July 11, 1985 and is headquartered in Ottawa, Canada. | Finance |
